Facebook
Twitter
Google+
LinkedIn
Pinterest
+
Leukemia Drug 'Nilotinib' Can Cure Dementia And Parkinson's, Claims Study
A recent study by US Food and Drug Administration has claimed that leukemia drug ‘Nilotinib’ also haS potential of curing acute diseases like dementia and Parkinson’s.

A recent study by US Food and Drug Administration has claimed that leukemia drug ‘Nilotinib’ also has potential of curing acute diseases like dementia and Parkinson’s.

The findings were reported in the Journal of Parkinson’s Disease.

ALSO READ:Getting Forgetful Could Be Sign Of Dementia

Parkinson’s disease (PD) is the second most common neurodegenerative disorder that causes a range of motor and non-motor symptoms.

During the course of the disease, dopamine (DA)-producing neurons are lost and bundles of proteins known as Lewy Bodies (LBs) form in the brain.

ALSO READ:Dementia Drugs Can Cause Harmful Weight Loss

The researchers found that the leukemia drug nilotinib can restore brain dopamine and reduce toxic proteins associated with Lewy Bodies formation in Parkinson’s disease and dementia patients.

(With IANS Inputs)